A new drug candidate has shown impressive results in a mid-stage clinical trial for drug-resistant epilepsy, raising hopes for patients who continue to suffer seizures despite being on multiple ...

Epilepsy is one of the most common neurological disorders, affecting 3.4 million Americans or 1 in 26 over a lifetime. The hallmark of epilepsy is seizures caused by abnormal bursts of electrical ...

Seizure control may take time—often a year or more—but most patients achieve it, bringing new hope for life with epilepsy. For millions of people living with ...

Researchers are optimistic after early results showed that experimental drug treatment zorevunersen may significantly reduce the number of seizures in children with a rare and severe form of epilepsy.

Longitudinal data suggested that treatment-resistant focal epilepsy may improve over time. Nearly 70% had reduced seizure frequency and some patients achieved seizure freedom. Improvement was not ...

“It’s all about the brain,” said Jennifer DeWolfe, D.O., professor in the UAB Department of Neurology. “Seizure manifestations are stereotyped, so the same symptoms occur with each seizure that ...

Epilepsy is among the most common neurological conditions, marked by unpredictable seizures, accidents and injuries, reduced quality of life, stigma and—in the worst case—premature death. But a ...

Epilepsy is a common neurological disorder that affects millions of people worldwide. Characterized primarily by seizures, epilepsy can present in a variety of ways depending on the individual and the ...

Please provide your email address to receive an email when new articles are posted on . Seizure freedom was observed by 12 months and continued past 48 months of the open-label extension. Long-term ...

How Does Fintepla Work for Seizures? Seizures are caused by sudden electrical activity changes in the brain. These changes are temporary but result in changes in movement, behavior, sensation, or ...